Treatment of congenital cytomegalovirus: where are we now? (Q36839732)

16 August 2017

1 reference

title

Treatment of congenital cytomegalovirus: where are we now? (English)

1 reference

16 August 2017

0 references

0 references

Marian G Michaels

1

1 reference

16 August 2017

1 June 2007

1 reference

Expert Review of Anti-infective Therapy

16 August 2017

1 reference

16 August 2017

5

1 reference

16 August 2017

441-448

1 reference

16 August 2017

3

1 reference

Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection.

16 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Maternal immunity and prevention of congenital cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Prenatal indicators of congenital cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Predictors of hearing loss in children with symptomatic congenital cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Effect of Leukocyte Interferon on Urinary Excretion of Cytomegalovirus by Infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Effectiveness of aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Cytomegalovirus prophylaxis using oral ganciclovir or valganciclovir in kidney and pancreas-kidney transplantation under antibody preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Variability in standard care for cytomegalovirus prevention and detection in pediatric lung transplantation: survey of eight pediatric lung transplant programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Foscarnet therapy for congenital cytomegalovirus liver fibrosis following prenatal ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Effect of maternal treatment with cyclic HPMPC in the guinea pig model of congenital cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Cyclic cidofovir (cHPMPC) prevents congenital cytomegalovirus infection in a guinea pig model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Intrauterine therapy for a cytomegalovirus-infected symptomatic fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Prevention of child-to-mother transmission of cytomegalovirus among pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

Fatal congenital cytomegalovirus infection acquired by an intra-uterine transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.3.441

21 January 2018

Identifiers

DOI

10.1586/14787210.5.3.441

1 reference

16 August 2017

1 reference

PubMed ID

17547508